Speakers

Professor Mark Baker

Session: Update on changes to NICE's guidance manual  

Professor Mark Baker
Centre for Guidelines Director
NICE

Mark Baker is the Director of the Centre for Guidelines (CfG) and is responsible for designing and operating methods and systems to produce clinical guidelines for the NHS. CfG is also responsible for the work of the Medicines and Prescribing Centre including summaries of evidence on new medicines and unlicensed and off-label medicines and the management of the contract for the British National Formulary.

Before joining NICE, Mark was Lead Cancer Clinician at the Leeds Teaching Hospitals and National Clinical Lead for Cancer Peer Review. He has previously worked in transplantation, academic medicine and public health medicine and was Chief Executive of Bradford Teaching Hospitals for six years and a Director of Research and Development. 


 

Dr Deyo Okubadejo

Session: Managing care for patients with multimorbidities

Dr Deyo Okubadejo
Chair, East Anglia Region​ 
British Geriatric Society

I am a Consultant in Medicine for Older People at the North West Anglia NHS Foundation Trust. I went to Medical School at St. Bartholomew’s Hospital, London and I did my Geriatric Registrar training in East London. I undertook research in Respiratory Disease in Older People at the London Chest Hospital. I have worked as a Consultant in Peterborough and Stamford for 20 years now and I have a fantastic job! As a Consultant Geriatrician I have worked in the community as well as the acute hospital. I run a Falls clinic and have an interest in Older People’s Mental Health. I see patients admitted on our adult acute medicine take. In 2014 I helped establish the Frailty Service in Peterborough. Having previously been a Clinical Lead for Medicine and Medicine for Older People I have recently taken on the role as Clinical Lead for Medical Admissions Unit and the Frailty Unit at Peterborough City Hospital. I am also currently Chair of the East Anglia Region branch of the British Geriatric Society. The main attraction of my role for me is that I enjoy the challenge of managing patients with multimorbidities. Every day is different and every patient is different.

Twitter: @DeyoOkubadejo​

LinkedIn: www.linkedin.com/in/deyo-okubadejo-1a901915a/​


 

Harriet Unsworth

Session: Apps and wearables

Harriet Unsworth
Senior Technical Analyst
NICE

Harriet Unsworth is a senior technical analyst at NICE. She is the technical lead for NICE’s evaluations of digitally enabled psychological therapies for use in IAPT services. Before this, Harriet was part of NICE’s medical technologies evaluation programme, where she helped to build the medtech innovation briefing programme. Her professional interests lie in the challenges and opportunities of evaluating digital healthcare technologies. Harriet has a PhD in molecular biology and worked in cancer research before joining NICE. 


 

David Thomson

Session: On the front line of innovation - insights from the Cancer Drugs Fund

David Thomson
Chemotherapy Pharmacist
NHS England Chemotherapy CRG & National Cancer Drug Fund

David is a cancer pharmacist working for NHS England (NHSE) to provide lead support and expert oncology pharmacy advice to the Cancer Drugs Fund (CDF) and to the Chemotherapy Clinical Reference Group (CRG). In that role he is involved in the development and implementation of policy on funding of cancer drugs in England. Prior to this role David worked as a haematology pharmacist in Leeds Teaching Hospitals NHS Trust and then as lead cancer pharmacist for the Yorkshire Cancer Network (YCN). During his time working for the YCN David chaired the Cancer Network Pharmacist Forum and worked closely with the National Cancer Action Team (NCAT) and other relevant national bodies on relevant issues affecting chemotherapy services and cancer drug access, eventually being seconded to work part-time for NCAT to support the CDF. David is a previous Chair of the British Oncology Pharmacists Association (BOPA), a Fellow of the Royal Pharmaceutical Society and has recently successfully completed an MSc in International Health Technology Appraisal, Pricing and Reimbursement.


 

Andrew Davies

Session chair: ​HealthTech Connect - Speeding up adoption of innovative devices and diagnostics

Andrew Davies
Director, Market Access
ABHI

Andrew joined the ABHI is 2103 and has responsibility for ensuring that processes are aligned and optimised to support the introduction and uptake of technologies and best practices. This entails creating an on going dialogue between industry and policy makers to ensure efficient and effective access and payment structures are created and maintained.

In addition to the Market Access portfolio Andrew also leads on the ABHI Ethics and Compliance program. This includes credentialing, Code of Business Practice and Human Rights.

Having graduated with a degree in Applied Physics, Andrew entered the commercial environment and has gained over 20 years experience in the medical devices industry having worked within medical technology divisions of household names such as Thorn EMI, Philips and Bristol-Myers Squibb. He has held roles covering UK and international marketing, market access and business development working with both capital and consumable equipment.

LinkedIn: https://www.linkedin.com/in/ardavies/


 

Sir David Haslam

Session: Opening chair

Sir David Haslam
Chair
NICE

Sir David Haslam is Chair of the National Institute for Health and Care Excellence (NICE). He is also past-President and past Chairman of Council of the Royal College of General Practitioners, past-President of the British Medical Association, a former vice-chairman of the Academy of Medical Royal Colleges, visiting Professor in Primary Health Care at de Montfort University, Leicester, and Professor of General Practice at the University of Nicosia, Cyprus. He was a GP in Ramsey, Cambridgeshire, for over 35 years and has been an expert member of the NHS National Quality Board, and National Clinical Adviser to both the Care Quality Commission and the Healthcare Commission. He is a Director of the State Health Services Organisation in Cyprus.

He is a Fellow of the Royal College of GPs, a Fellow of the Faculty of Public Health, a Fellow of the Academy of Medical Educators, a Fellow of the Royal Society of Medicine, and a Fellow of the Royal College of Physicians.

He has written 13 books, mainly on health topics for the lay public and translated into 13 languages, and well over two thousand articles for the medical and lay press. In 2014 he was named by Debretts and the Sunday Times as one of the 500 most influential and inspirational people in the United Kingdom. He was awarded CBE in 2004 for services to Medicine and Health Care, knighted in 2018 for services to NHS Leadership, and has been awarded Honorary Doctorates by Birmingham University and the University of East Anglia.


 

Dr Tracey Vell MBE

Session: Behind the scenes in Greater Manchester.

Dr Tracey Vell
CE MANCHESTER LMC and Associate lead for Primary and Community care GMHSCP

Dr Vell has worked in the NHS for 27 years and  general practice for over 23 years. She joined the LMC 23 years ago as a GP Registrar representative and has been chair and now Chief Executive.

In 1997 she set up a limited company as a local co-operative to do out of hours work called Mandoc (Manchester Doctors On call) to enable the GP contract to be split and deliver safe OOH care to patients.

In 2014 Dr Vell took the Chair of the Association of 7 Greater Manchester LMCs. She persevered to bring the primary care provider voice to the GMH&SC Devolution programme and now works as a part of the senior management team.

She also works nationally on the new models of care technical committee working on the new MCP contract.

She supports,advises and works amongst grass-root GPs.

Twitter: @TraceyVell


 

Mirella Marlow

Session: HealthTech Connect - Speeding up adoption of innovative devices and diagnostics

Mirella Marlow
Programme Director Devices and Diagnostic Systems
NICE

Mirella Marlow is responsible for NICE’s programmes that evaluate and develop guidance on medical devices, diagnostics and interventional procedures.  She works with the medtech industry, health services, government policymakers, lifesciences organisations and researchers to maximise the effectiveness of NICE’s work in these areas.   Mirella joined NICE in 2004, having previously worked for 15 years as a commissioner in the NHS. She has an MBA and a Masters in Medical Ethics and Law from Keele University. Her interests in medical ethics include measuring cost-effectiveness of interventions to improve safety in healthcare, and incorporating ethical considerations into HTA.  


 

Dr Kim Holt

Session: Integrating and leading patient centred systems

Dr Kim Holt
Designated Doctor safeguarding and Child Death review
Haringey CCG
 

Kim Holt is a Consultant paediatrician, trained in London and Manchester. Her first consultant post was in Salford where she developed a “one stop shop “, for children with visual impairment. Always striving for excellence in community child health provision, she was a member of a newly formed community team recruited to develop and improve Community services in Haringey in 2004. Her experience in raising concerns, speaking up and campaigning for a “just culture” has led to her being awarded national clinical leadership awards. She currently works as Designated doctor for Safeguarding in Haringey and continues to contribute to improving services in the borough, and patient safety.

Dr Holt contributed to the Speak up review Chaired by Sir Robert Francis, and also made a significant contribution to the review of how the GMC responds to whistleblowers led by Sir Anthony Hooper . She continues to campaign on issues related to how the GMC operate and supports the challenge to them regards Dr Hadiza Bawa. (a fellow paediatrician).

She  chaired the campaign group Patients First campaign since its formation in December 2011 , and as such presented oral evidence to the Health Select Committee in March 2014. The evidence presented by Patients First was instrumental in bringing speaking up into the mainstream and bringing a renewed focus on the importance of clinical governance and staff engagement.

In 2015 Kim was interviewed as one of the Kings Fund recognised system leaders in 2015, because of the efforts that she made to raise awareness of the challenges of speaking up and how that had influenced the debate. That was a great honour.

In 2018 she graduated as a Nye Bevan leader from the NHS leadership academy.

Kim herself says that she had not recognised herself as a leader until she was tested by the system during the period 2006-2009  she was trying to raise concerns and speak about her department. She recognises the importance of conversations, truthfulness as well as courage in being a system leader, and how important it is to develop and maintain resilience.


 

Jo Jerrome

Session: Shared decision-making and patient empowerment

Jo Jerrome
CEO
Thrombosis UK
 

Jo began working with Thrombosis UK in 2015 and was appointed as the charity’s first CEO in 2016.

A teacher for many years, Jo became involved in health, and patient advocacy following her young daughter's diagnosis of a long-term condition.

Jo has particular interest in the impact living with long-term health conditions can have on individuals and is a passionate advocate of the benefits informed, supported decision making have on improving well-being as well as health outcomes.

Drawing upon her experience and professional training, Jo has collaborated on multiple programmes supporting the development of decision-making resources, including projects with NICE, Right Care, West of England AHSN and leading national charities.

Jo is a Lay Member on NICE Indicators Committee, a PPI representative on both the ED and Patient Safety collaborative run by WEAHSN and sits as a patient representative on a number of research studies.

Twitter: @JoJerrome  @ThrombosisUK

LinkedIn: https://www.linkedin.com/in/jojerrome/


 

Professor Gill Leng

Session: Uniting the science and practice of clinical improvement and Shared decision-making and patient empowerment  

Professor Gill Leng
Deputy Chief Executive and Health and Social Care Director 
NICE

Professor Gillian Leng is the Deputy Chief Executive at NICE, the Director of Health and Social Care, and a visiting professor at King's College London.

Gillian trained in medicine at Leeds, and then spent several years researching the epidemiology of peripheral vascular disease at Edinburgh University. She was involved in the Cochrane Collaboration as it first became established, and still contributes as an editor to the EPOC Group (Effective Practice and Organisation of Care). She specialised in public health medicine, and worked as a consultant before moving to NICE in 2001.

At NICE, Gillian has been responsible for the initial set up and running of the clinical guidelines programme, for establishing the NICE implementation function, and for setting up NHS Evidence. More recently she has been responsible for the transfer of the National Prescribing Centre into NICE, for establishing the NICE accreditation programme, and for new work on Quality Standards across health and social care.

Gillian is also Director of the Health and Social Care Programme and since January 2015 is leading the public health team at NICE.


 

Richard Preece

Session: Behind the scenes in Greater Manchester.​

Richard Preece
Executive Director
Quality First

Richard is Executive Lead for Quality and Medical Director of the Greater Manchester Health and Social Care Partnership.  He is the custodian of assurance processes, care experience and standards, and leads the collaborative approach to maximising care outcomes whilst eradicating health inequalities.  His team promote quality of care experience, innovation, productivity and prevention by driving transformation through systems that make it easy to get it right (and hard to get it wrong) and focus on learning.  He is Responsible Officer for a number of Greater Manchester programmes including those for cancer, maternity and medicines management.

He began his career serving in the Royal Navy before holding roles in both the public and independent sectors.

His research interest has focused on quality improvement and clinical performance improvement.  He is an alumnus of the NICE Fellowship programme and designed and led the first ever national audit of implementation of NICE workplace health guidance in NHS trusts.

Richard has been a school governor and trustee for the primary school he attended for more than a decade.  Away from work he enjoys skiing and athletic pilates.

Twitter: @drrichardp


 

Nicola Bent

Session: Integrating and leading patient-centred systems

Nicola Bent
Programme Director - System Engagement
NICE

Nicola Bent is the Programme Director for System engagement at NICE, working in the Health and Social Care Directorate. She is a registered pharmacist and has extensive experience at a national, regional and local level having worked across the NHS for the past 20 years in a variety of roles in primary and secondary care around clinical pharmacy, medicines management, commissioning and quality improvement.

She now has responsibility for the Institute’s strategic engagement activities at a regional and local level across the health and care system. She also leads on the NICE implementation strategy and is responsible for the implementation support function, the Fellows and Scholars programmes and NICE’s quality assurance work. She was responsible for setting up the NICE work programme for social care and led on the initial set up and running of the quality standards and indicators programmes.


 

Suzanne Rankin

Session: Getting it right first time

Suzanne Rankin
CEO
Ashford and St Peter's Hospitals NHS Foundation Trust

Suzanne joined Ashford and St. Peter’s in December 2010 as the Chief Nurse before securing the post of Chief Executive in September 2014.

Prior to joining the Trust, she held the post of Deputy Chief Nurse for NHS South Central where she worked across the region in the implementation of the Nursing and Midwifery Strategy as well as many clinical quality improvement and assurance initiatives.

Prior to that, Suzanne’s nursing and management career was exclusively with the Royal Navy and included deployment during the 1990 Gulf War; a spell as Senior Nursing Officer at NATO HQ Lisbon and deployment to both Iraq and Afghanistan. Her final post with the Royal Navy was within the Surgeon General’s Department at the Ministry of Defence.

Since joining the Trust she has led the strategic transformation and modernisation of the nursing and midwifery workforce, as well as wider work across the organisation to transform the approach and culture around patient safety and clinical quality improvement. The sole intent of this work has been to improve patient experience and safety with the consequent positive impact on organisational performance. 

Since appointment to the role of Chief Executive in 2014 Suzanne has focused on creating the “right culture” with Team ASPH enabling the delivery of the highest quality care and treatment. Achieving the Trust  mission of the provision of high quality sustainable healthcare has been enabled by a strong commitment to the principles of the Get it Right First Time Programme and Suzanne and her team have been successful in implementing the approach across a number of specialities. The appointment of Trust GIRFT Clinical Leads and a Programme Director is supporting the roll-out of the approach across the whole Trust at scale and pace. 

Suzanne is the Senior Responsible Officer for the Surrey Heartlands STP Workforce Workstream and is leading delivery of the STP’s “One Team” vision.


 

Emily Crossley

Session: Roadmap for life sciences - interactive session

Emily Crossley
Co-Founder, Co-CEO
Duchenne UK

Emily is the co-founder and joint CEO of Duchenne UK.

Duchenne UK is a lean and ambitious charity, focused on funding and accelerating research to find treatments and a cure for Duchenne Muscular Dystrophy for this generation of patients. Emily works alongside co-founder, Alex Johnson to strategically fund research along every stage of the drug development pipeline, to leverage their advocacy and financial support to accelerate research. They work closely with Duchenne UK's Director of Research and the Scientific Advisory Board to spend money in the most effective way to bring treatments to this generation of patients.

Duchenne UK has raised over £10million in the last 5 years, and spent £6.5million and committed £3.5million on direct grants for research and clinical trials.

In 2017 Alex and Emily received a Points of Light award from the Office of the Prime Minister for their transformational work on Duchenne research. 

Twitter: @duchenneuk

Linkedin: www.linkedin.com/in/emily-crossley-44571b43/


 

Sir Andrew Dillon

Chair: On the front line of innovation - insights from the Cancer Drugs Fund and Early Access to Medicines Scheme

Sir Andrew Dillon
Chief Executive
NICE

Sir Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.


 

Professor Tim Briggs CBE

Session: Right first time

Professor Tim Briggs CBE
Chair of Getting it Right First Time
GIRFT Programme

Professor Briggs qualified from The Royal London Hospital in 1982 with honours in surgery and a number of prizes. After his senior registrar training he was appointed to the Royal National Orthopaedic Hospital as Consultant in 1992. His specialist interests are in orthopaedic oncology as well as surgery to the hip and knee. He was Medical Director at the RNOH for 15 years, ensuring a re-build and was President of the British Orthopaedic Association in 2014.

He was appointed as National Director for Clinical Quality and Efficiency for the NHS in September 2015 and has been asked to lead and roll out his GIRFT methodology, developed in orthopaedics, across all surgical and medical specialities within the provider network.

Professor Briggs was made a Commander of the Most Excellent Order of the British Empire (CBE) in the 2018 New Year’s Honours List for services to the surgical profession.


 

Chris Connell

Session: Implementation workshop - After the NICE recommendation: using guidance with limited resources

Chris Connell
Associate Director – Field Team (South) and Sector Lead for social care 
NICE

Chris Connell is Associate Director with the NICE Field Team covering the south of England.  His responsibilities include; helping organisations adopt and implement NICE guidance; ensuring that they are kept up to date on latest developments and making sure that the views of users are fed back and reflected in the  work of the Institute.

Before joining NICE, Chris was General Manager for Medicine and A&E at Worcestershire Acute Hospitals NHS Trust Chris has previously worked in Gloucester, Norwich, Birmingham and Walsall. He has sixteen years experience of operational management within the NHS, covering most acute specialties as well as mental health.  

Chris holds a masters degree in public services management from Aston Business School and a postgraduate diploma in health services management.


 

Dr Linda Landells

Session: On the frontline of innovation – insights from the Cancer Drugs Fund

Dr Linda Landells
Associate Director, Technology Appraisals (Cancer Drugs Fund)
NICE

Dr Linda Landells is an Associate Director in the Technology Appraisals team at NICE. She has responsibility for looking after treatments that enter the Cancer Drugs Fund. In her previous position in the Highly Specialised Technologies team, she gained experience in developing managed access agreements with NHS England. Before joining NICE, Linda worked in medical communications, engaging with top global pharmaceutical companies in strategic publications planning and key opinion leader development. She has a PhD in Immunopharmacology and has held research posts in industry and academia.


 

Dr Amina Aitsi-Selmi

Session: Managing care for patients with multimorbidities – case studies of implementing NICE guidance

Dr Amina Aitsi-Selmi
Honorary Clinical Senior Lecturer, Epidemiology and Public Health Department
University College London

Dr Amina Aitsi-Selmi MBBChir MRCP MPH MFPH PhD qualified in medicine from Cambridge University in 2002 and pursued a career in international health. Over a 13 year span she journeyed from local NHS hospital doctor to advising the United Nations on Disaster Risk Reduction and the Sustainable Development Goals in her role as a Consultant in Public Health at PHE. After gaining a PhD in Epidemiology at UCL supervised by Professor Sir Michael Marmot, she worked for the Department of Health on a national framework for action on multimorbidity and continued to contribute to this agenda locally and nationally as a NICE Fellow. She is currently Director of an independent coaching and consulting practice in which her knowledge of the wider determinants of health and wellbeing as well as her personal experience is translated into helping doctors and professionals to perform with less stress and more joy, wisdom and contentment.

Twitter: @DoctorAminaUK
LinkedIn: www.linkedin.com/in/dr-amina-aitsi-selmi-mbbchir-mrcp-mph-mfph-phd-8069307


 

Carla Deakin

Sessions: Roadmap for life sciences - interactive workshop

Carla Deakin
Associate Director - NICE office for Market Access
NICE

Originally a biomedical scientist, Carla spent 25 years in the UK Diagnostics industry gaining both commercial and healthcare system experience in a variety of roles for a major global healthcare company. During this time, Carla was an active contributor in the UK laboratory diagnostics industry and professional body arena, holding a number of industry wide posts including that of chair of the executive board of BIVDA (British In-Vitro Diagnostics Association) 2012 – early 2014.

Carla joined NICE in February 2014 as Associate Director for the Diagnostics Assessment Programme, focusing in particular on raising the awareness of NICE’s diagnostics activities with external stakeholders. She became Associate Director for the NICE Office for Market Access in January 2017 and the Accelerated Access Collaborative Secretariat in January 2018. Carla holds an MSc in Health Economics and Health Policy from the University of Birmingham and was previously a Fellow of the Institute of Biomedical Sciences.

LinkedIn: www.linkedin.com/in/carladeakin/

Twitter: @carladeakin1


 

Conference Chair: Dr Phil Hammond

Conference Chair

Dr Phil Hammond

Dr Phil Hammond can talk seriously or humorously, and usually both, about any health and lifestyle topic. He has been an NHS doctor for 31 years, a comedian for 29 years, a BBC broadcaster for 28 years and Private Eye’s medical correspondent for 26 years. He qualified as a doctor in 1987, was a part time GP for 20 years, spent 5 years in sexual health and currently works in an NHS team helping young people with chronic fatigue. Phil presented five series of Trust Me, I’m a Doctor on BBC2, and has appeared many times on Have I Got News For You, the News Quiz, the Now Show and Countdown.

Phil has been a Lecturer in Medical Communication at the Universities of Birmingham and Bristol. As a journalist, he broke the story of the Bristol heart scandal in 1992, and gave evidence to the subsequent Public Inquiry. In 2012, Phil and Andrew Bousfield were shortlisted for the Martha Gellhorn Prize for investigative journalism for their Private Eye special report on the shocking treatment of NHS whistle-blowers, Shoot the Messenger. He has twice been named in the top 100 NHS Clinical Leaders by the Health Service Journal, and was voted Teacher of the Year by the medical students of Birmingham University.

Phil has presented his own BBC Radio Bristol show for 11 years, combining health, hope and happiness. With David Spicer, he has written 5 series of the medico-political satire ‘Polyoaks’ for Radio 4, and five books including ‘Staying Alive’ and ‘Sex, Sleep or Scrabble?.’ Phil was half of the award-winning comedy junior doctor double act Struck Off and Die with Tony Gardner, and has done four UK solo comedy tours, teaching audiences how to pleasure themselves sensibly and take the pressure off the NHS. His new show, ‘Happy Birthday NHS?’ celebrates its 70th birthday and provides a road map for its salvation. It tours in 2018.


 

Dr Samantha Roberts

Session: Implementing the Accelerated Access Review

Dr Samantha Roberts
Director of Innovation & Life Sciences
NHS England

Samantha Roberts has recently been appointed as NHS England's Director of Innovation and Life Sciences.

She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before joining McKinsey and Company where she worked in a wide range of industries before specialising in healthcare.

After McKinsey she moved into the NHS as a senior manager at a large teaching hospital in London (UCLH) and a director in an Academic Health Sciences Centre and Network (UCLPartners).

Over the last five years she has become involved in research, working with health economic models to inform evidence-based policy, initially at the London School of Economics before moving to the University of Oxford to undertake a DPhil (PhD).


 

Annie Coppell

Session: Implementation workshop - After the NICE recommendation: using guidance with limited resources

Annie Coppell
Associate Director – Field Team (North) and Sector Lead for Health
NICE

Annie joined NICE in 2006 and in her current role as Associate Director – Field Team (North) is responsible for strategic engagement across the North of England. Working with arm’s length bodies, system partners and with NHS and social care commissioners and provider organisations directly, she offers strategic support and advice to enable best use of NICE guidance and quality standards to improve the quality of health and care services. A member of various local health economy steering/project groups she offers challenge and support on effective processes for use of NICE resources and quality improvement. Annie is a pharmacist with extensive experience of influencing evidence-based prescribing and medicines optimisation; also guidance implementation at local, regional and national levels.

Twitter: @coppel_annie​

LinkedIn: https://www.linkedin.com/in/annie-coppel-6297b718/


 

Donna Hakes

Session: HealthTech Connect - Speeding up adoption of innovative devices and diagnostics

Donna Hakes
​Head of Clinical Effectiveness, Specialised Commissioning​
NHS England

A senior NHS manager, clinically trained, with extensive experience in operational and clinical effectiveness, quality improvement and its application in practice. Experience in working across health sectors from acute care, Dept of Health performance support to commissioning in both primary and specialised services.

Expertise in working with multi-professional teams and supporting a broad range of staff groups to achieve successful policy development, redesign of services and management/clinical practices.

As Head of Clinical Effectiveness within the NHS England specialised commissioning team, Donna leads the national clinical policy development programme, of which horizon scanning is an important aspect, and NHS England’s Individual Funding Request system.


 

Meindert Boysen

Session: Implementing the Accelerated Access Review​

Meindert Boysen
Director, Centre for Health Technology Evaluation
NICE

Meindert is Director of the Centre for Health Technology Evaluation. After qualifying as a pharmacist, he worked in a hospital in the Netherlands, and held positions in health outcomes and sales in the pharmaceutical industry.

Meindert completed an MSc in Health Policy Planning and Financing at The London School of Hygiene and Tropical Medicine and the London School of Economics & Political Sciences and briefly worked for the King’s Fund before starting at NICE in 2004. Meindert is currently on the board of directors for ISPOR (The International Society for Pharmacoeconomics and Outcomes Research), 2017 – 2020.

LinkedIn: www.linkedin.com/in/meindert-boysen-pharmd-msc-63a498/


 

Professor John Appleby

Session: Closing debate - Future Shock

Professor John Appleby 

Director of Research and Chief Economist
Nuffield Trust AHSNs

John Appleby joined the Nuffield Trust as Director of Research and Chief Economist in 2016 following his position at the King’s Fund as Chief Economist, and senior lectureships in health economics at the Universities of East Anglia and Birmingham. After his masters in health economics at the University of York in 1980, he worked in the NHS for seven years in Birmingham and London.  John has published widely on a range of health care finance and economic issues in books, academic journals, reports, magazines and newspapers. He is a regular columnist for the British Medical Journal. As well as his post at the King’s Fund, John is a Visiting Professor at the Department of Economics, City University, London, and at the Institute of Global Innovations at Imperial College London.  


 

Jenniffer Prescott

Session: Roadmap for life sciences - interactive session

Jenniffer Prescott
CHTE Associate Director – Planning, operations and topic selection 
NICE

Jen Prescott is the Associate Director for Planning, Operations and Topic Selection, working within the Centre for Health Technology Evaluation at NICE.  Jen started working in the NHS in 2002 and spent the next few years working on the development and implementation of an Electronic Patient Record (EPR) system at a Lancashire based Trust.  In 2007, she moved to NICE as a Project Manager, and in 2010 moved into the Associate Director position for planning and operations. In August 2015, Jen also took over responsibility for the Topic Selection function for Technology Appraisals and Highly Specialised Technolgies.


 

Su Jones

Session: Getting the most value out of medicines

Su Jones
NHS Engagement Partner, National lead for Accelerating Access & Uptake
The Association of the British Pharmaceutical Industry

Su Jones leads the ABPI’s agenda for change around accelerating access and uptake of NICE approved medicines influencing positive policy change.  Her role in the ABPI involves cross-functional working with members, NHS England organisations and relevant stakeholders. She represents members on an extensive breadth of  Boards ranging from European Federation of Pharmaceutical Industries and Associations Health Systems Working Group, NICE Implementation Collaborative, Innovation Score Card Strategic Metrics Group ,  West Midlands AHSN and East Midlands Digital Innovation Program Board . She chairs the NHS Expert Network, which represents members in the Midlands and East, and co-chairs the national Taskforce for Lung Health. Su brings to the ABPI a wealth of experience in national market access and business management roles, alongside broad and varied experience of leading successful partnerships with the NHS in the course of her career.


 

Dr Rosie Benneyworth

Session: Integrating and leading patient-centred systems

Dr Rosie Benneyworth
Director of Strategic Clinical Services Transformation
Somerset Clinical Commissioning Group

Rosie has been a Non-Executive Director with NICE since January 2016 and Vice Chair since May 2017 where she oversees the technology appraisals and highly specialised technologies appeals process. She has been involved with NICE for several years, having previously been a member of a guideline development group and a NICE Fellow.

Rosie currently works as the Director of Strategic Clinical Services Transformation for Somerset Clinical Commissioning Group, where she is responsible for developing and implementing a joint commissioning strategy with the local authority for the Somerset population.

She has been a GP for 15 years and worked as a principal, salaried and sessional GP during this time. Prior to her current role, Rosie was Managing Director of the South West Academic Health Science Network (AHSN), where she was Vice Chair of the AHSN network and led the Patient Safety Collaboratives. Rosie has also held many clinical leadership roles mainly around service redesign and improvement programmes.


 

Nick Crabb

Session: Tackling antimicrobial resistance globally and locally

Nick Crabb
Programme Director – Scientific Affairs
NICE

Nick had a 20 year career in analytical science, process technology and general management in the chemical, pharmaceutical and contract laboratory industries prior to joining NICE as the associate director for the Diagnostics Assessment Programme in 2010. Nick was responsible for the establishment and management of the programme. In 2014 Nick was appointed Programme Director for Scientific Affairs where he oversees NICE Scientific Advice, the Science Policy and Research programme and the NICE Office for Market Access.


 

‘Bunmi Fajemisin

Session: Getting the most value out of medicines

‘Bunmi Fajemisin
Lead Pharmacist – Medicines Effectiveness, Logistics and Technology 
Oxford University Hospitals NHS Foundation Trust

‘Bunmi is a hospital pharmacist with more than 25 years of experience in implementation of evidence based medicines management projects in acute NHS care.  He is currently the lead pharmacist for clinical effectiveness, logistics and technology in Oxford University Hospitals NHS Foundation Trust.   Bunmi has a wealth of experience in change management, and is a member of the senior pharmacy management team in Oxford. His key responsibilities include Formulary Management; Cost Improvement of Medicines; Contracting of pharmaceuticals and pharmaceutical services; as well as electronic prescribing. His past experience include being a hospital specialist pharmacists in Critical and Cardiac care. 

LinkedIn: www.linkedin.com/in/bunmi-fajemisin-03130620/


 

Paul Catchpole

Session: Getting it right first time

Dr Paul Catchpole
Value & Access Director
ABPI

Paul has worked in the healthcare, local government and pharmaceutical sectors for over 30 years. He began his career as a researcher and then held a number of NHS management posts before working on a wide range of UK and international management consultancy assignments at PriceWaterhouseCoopers.  After moving to Roche Pharmaceuticals he led work on national reimbursement of medicines, health economics, strategic pricing, strategic funding and capacity and market access. 

Paul’s work at the ABPI over the last eight years covers the evaluation of medicines, pricing & reimbursement, health technology assessment, the cancer drugs fund, biological medicines, including biosimilar medicines, the Accelerated Access Collaborative and negotiations on the current and next Pharmaceutical Price Regulation Scheme (PPRS).

He has a Ph.D in healthcare information systems and is a Member of the British Computer Society; a Chartered Information Technology Professional; and Member of the Institute of Healthcare Management.


 

Paula Whitty

Session: Implementation workshop - After the NICE recommendation: using guidance with limited resources

Paula Whitty
Joint Director of Research, Innovation and Clinical Effectiveness
Northumberland, Tyne and Wear NHS Foundation Trust

Paula Whitty is the (joint) Director of Research, Innovation and Clinical Effectiveness at Northumberland, Tyne and Wear (NTW) NHS Foundation Trust as well as the Director of the North East Quality Observatory Service (NEQOS)(www.neqos.nhs.uk). Her portfolio at NTW has included Director-level responsibility for the implementation of NICE guidance within the Trust. Previous posts include the national Lead for the ‘Better Metrics’ project and the Clinical Effectiveness Lead at the (former) Healthcare Commission. Originally trained as a consultant in Public Health, Paula continues to be an accredited Public Health Physician and has a Doctorate in patient-reported outcome measurement.

Paula’s other previous research interests were in ‘implementation research’ and evaluation, including as a collaborator on the Durham University/Newcastle University evaluation of the ‘North East Transformation System’. As well as an Honorary Professor at Durham University, Paula is also an Honorary Clinical Senior Lecturer at Newcastle University.

Twitter: @WhittyPaula

Twitter (NEQOS): @nhs_quality

Linked in: www.linkedin.com/in/paula-whitty-a1bb1bb/


 

Professor Martin Marshall

Session: Uniting the science and practice of clinical improvement

Prof Martin Marshall
Professor of Healthcare Improvement
University College London

I am Professor of Healthcare Improvement at UCL and lead for Improvement Science London, an initiative to promote the science of improvement across  through collaboration between academics and practitioners. Prior to this role I was Clinical Director and Director of R&D at the Health Foundation between 2007 and 2012, Deputy Chief Medical Officer and Director General with responsibility for clinical quality and safety and medical education in the Department of Health from 2006 to 2007, and Head of the Division of Primary Care and Professor of General Practice at the National Primary Care Research and Development Centre, University of Manchester from 1999 to 2006. 

I have worked as general practitioner for over 26 years, currently in an inner city practice in Newham, East London, am a fellow of the Royal College of General Practitioners and a member of College Council. I am also a fellow of the Royal College of Physicians and the Faculty of Public Health Medicine. I was a non-executive director of the Care Quality Commission, the national regulator for health and social care, between 2008 and 2012.

I was a Harkness Fellow in Health Care Policy in 1998/99, based at the RAND Corporation, California and have advised health and professional bodies, governments and international organizations around the world. I have written over 190 publications in the field of quality of care. I am a past President of the European Society for Quality Improvement in Family Practice. In 2005 I was awarded a CBE in the Queen’s Birthday Honours list for Services to Health Care.


 

Steve Turner

Session: Managing care for patients with multimorbidities - case studies of implementing NICE guidance

Steve Turner
NICE Medicines and Prescribing Centre Associate
Care Right Now

Steve has a strong background in healthcare service delivery and information technology. He has held the posts of Head of I.T. in an NHS Trust, and a high performing Senior Healthcare Consultant for a US company. Steve is a registered general and mental health nurse prescriber, having worked successfully on the front line in an assertive outreach team.

He is Managing Director of Care Right Now (CIC); a NICE Medicines & Prescribing Associate and Head of Medicines & Prescribing @MedicineGov.  

Recently Steve has been working on multimorbiditiy, delivering ‘patient led clinical education’ to groups and individuals with complex needs.

This has led to the development of a novel approach to patient education, which involves patients with multiple long term conditions reviewing their medicines in a session with health professionals, and providing people with their own notes in the form of a written action plan, which they can share with clinicians.

Twitter: @MedicineGovSte

LinkedIn: https://www.linkedin.com/in/sjturner/


 

Professor Stephen Powis BSc (Hons) BM BCh PhD MBA FRCP

Session: Closing debate - Future Shock​

Professor Stephen Powis
National Medical Director
NHS England

Stephen Powis is the National Medical Director of NHS England and Professor of Renal Medicine at University College London.

Previously he was Medical Director (and latterly Group Chief Medical Officer) of the Royal Free London NHS Foundation Trust from 2006 to 2018. Professor Powis was also a member of the governing body of Merton Clinical Commissioning Group for five years and a Director of Healthcare Services Laboratories LLP. He is a past Chairman of the Association of UK Universities (AUKUH) Medical Directors Group and has been a member of numerous national committees and working groups, including the Department of Health Strategic Education Funding Expert Group. He is a past non-executive director of the North Middlesex University Hospital NHS Trust, including a period of eight months as acting chairman.

He is a past chairman of the Joint Royal Colleges of Physicians Training Board (JRCPTB) Specialty Advisory Committee (SAC) for Renal Medicine and a former board member of Medical Education England. He was Director of Postgraduate Medical and Dental Education for UCLPartners from 2010-13. He is a past treasurer and trustee of the British Transplantation Society and a former member of the UK Transplant Kidney Pancreas Advisory Group. He has also served as a member of the Renal Association Executive Committee. He was Editor of the journal Nephron Clinical Practice from 2003 to 2008. In 2017 he became the inaugural Editor-in-Chief of the journal BMJ Leader. He has been a trustee of several charities, including the Royal Free Charity and the Healthcare Management Trust. 


 

Eugene Benson

Session: On the frontline of innovation – insights from the Cancer Drugs Fund

Eugene Benson
Senior National Market Access Manager​
Takeda UK

Eugene is Associate Director of Market Access at Takeda UK. In this role he is jointly responsible for submissions to UK HTA bodies, including NICE, with the overall objective of securing patient access to Takeda’s medicines. His role also involves being a strategic professional ambassador for Takeda, building long-term relationships throughout the HTA and payer communities. Eugene has worked in pharmaceuticals for over 20 years, initially as a strategic management consultant for over 7 years before joining Takeda in 2005. Prior to this, he practised as a Clinical Pharmacist in the NHS. In addition to a degree in pharmacy he also has a MSc. in Clinical Pharmacology.

He has experience of working with the Cancer Drugs Fund (CDF), including on Takeda’s lymphoma medicine Adcetris® (brentuximab vedotin) which recently became the first medicine to be reappraised and recommended for routine NHS use following data collection in the new CDF.


 

Celia Ingham Clark

Session: Uniting the science and practice of clinical improvement

Celia Ingham Clark
Medical Director for Clinical Effectiveness
NHS England

Celia Ingham Clark is the Medical Director for Clinical Effectiveness at NHS England.

She trained in Cambridge and London and was appointed as a consultant general surgeon at the Whittington Hospital in 1996.

After early work in medical education she developed an interest in quality improvement and this took her through several medical management roles to become Medical Director of the trust from 2004-2012.

More recently she worked as national clinical director for acute surgery and enhanced recovery, and as London regional lead for revalidation and quality.

For two years from 2014 she was the NHS England Director for reducing premature mortality, and in 2016 became the Medical Director for Clinical Effectiveness.

She was awarded an MBE in 2013 for services to the NHS.


 

Professor Michael Trenell

Session: What can big data analytics achieve for healthcare?

Professor Michael Trenell
Director
National Institute for Health Research Innovation Observatory

Mike is Director of the National Institute for Health Research Innovation Observatory and a former NIHR Senior Fellow. He has a specialist interest in health innovation – how new ‘things’ are developed in the healthcare sector and how they can implemented. A clinical scientist by training, he has worked significantly on how lifestyle influences lifelong health and wellbeing and chronic disease, particularly diabetes, cardiovascular disease, dementia and stroke. His NIHR funded research has been focussed on digital health and self-care where he has worked with several industrial and academic partners in the US and Europe. With the NIHR Innovation Observatory Mike is leading a team which is working with the NHS, NICE, academia, industry and government to identify the next generation of drugs, diagnostics, devices and services.

Twitter: @miketrenell​

LinkedIn: https://uk.linkedin.com/in/michaeltrenell


Professor Alf Collins

Session: Shared decision-making and patient empowerment

Professor Alf Collins
National Policy Advisor, Person-centred Care
NHS England

Professor Alf Collins is a doctor, commissioner, researcher and national policy advisor in person-centred care.

He has researched and published widely on self-management support, shared decision making, care planning, co-production, patient activation and patient engagement.

Alf has worked with others to develop a number of measures of person-centred care, including the ‘clinician support for patient activation measure’.

He has a visiting professorship in person-centred care from Coventry University and Honorary Fellowships at the Royal College of Physicians and the Royal College of General Practitioners.

Twitter: @alf_collins


 

Professor Andrew Morris CBE MSc MD FRCP (Edin, Glas) FRSE FMedSci

Session: Closing debate - Future Shock

Professor Andrew Morris
Director
Health Data Research UK

Since August 2017 Andrew Morris has been the inaugural Director of Health Data Research UK, the multi-funder UK Institute for health and biomedical informatics research that will capitalise on the UK’s renowned data resources and research strengths to transform lives through health data science. He is seconded from his position as Professor of Medicine, and Vice Principal of Data Science at the University of Edinburgh, having taken up position in August 2014.  Prior to this Andrew was Dean of Medicine at the University of Dundee. 

Andrew was Chief Scientist at the Scottish Government Health Directorate (2012-2017) and has served and chaired numerous national and international grant committees and Governmental bodies. He has published over 250 papers and been the PI on several programme grants from the Wellcome Trust, MRC and other funders. 

Twitter: @profadmorris​


 

Professor Carole Longson

Session: Future Shock – closing debate

Professor Carole Longson
Chief Scientific Officer
ABPI

Carole has a doctorate in Pharmacology, spending 8 years in drug discovery at GlaxoSmithKline on the identification and development of novel pharmaceuticals across multiple therapeutic areas.

A past president of Health Technology Assessment International, Carole has contributed to many international science and policy forums, including WHO advisory groups on Priority Medical Devices and

Innovative Technologies. Carole is a past member of the scientific committee of the European Commission Innovative Medicines Initiative and is Vice Chair of the Innovate UK Medicines Discovery Catapult.


 

Gary Leeming

Sessions: What can big data analytics achieve for healthcare?

Gary Leeming
Chief Technology Officer
Connected Health Cities

Gary Leeming is the Chief Technology Officer for Connected Health Cities, a programme developing a federated learning health system across the North of England, and using health informatics to deliver innovation in care and research. He was formerly responsible for Datawell, a programme creating easier methods for sharing of information for use by clinicians in the care of patients across Greater Manchester. Previously he has worked as COO for NorthWest EHealth where he led the development of the applications and databases for the Salford Lung Studies and the FARSITE project, amongst others. He also has wide experience in IT across the public and private sector.


 

Steve Sparks

Session: Getting it Right First Time

Steve Sparks
NHS RightCare Delivery Partner
NHS England

Steve joined NHS RightCare in January 2016, and is currently working with CCGs in East Surrey and Sussex and Berkshire, Oxfordshire and Buckinghamshire. Before joining NHS RightCare, Steve led the NICE field team of 8 implementation consultants for 9 1/2 years. This involved helping hospitals, commissioners and local authorities make the most of the evidence based products produced by NICE. 

Steve has always been motivated by helping patients and service users access the most effective treatments and services, but in a way that secures the long-term sustainability of the health and care system. Working with NHS RightCare provides Steve a great opportunity to pursue this with some really good new resources and approaches.

Prior to joining NICE, Steve worked as a commissioner of specialised and general acute services, was Deputy Secretary of the Barts and the London School of Medicine and Dentistry and held a number of senior positions in acute hospitals in London and on the South Coast. Steve also has an interest in health services organisational research and sits on the National Institute for Health Research’s Health Services and Delivery Research Board.

 


 

Diarmaid Crean

Session: Apps and wearables

Diarmaid Crean
Deputy Director of Digital
Public Health England

Diarmaid Crean is the Deputy Director for Digital at Public Health England (PHE) and joined the agency in August 2014.

He leads the overall digital strategy and products for PHE.

Prior to working at PHE, Diarmaid gained more than 24 years of experience in digital marketing, branding, e-commerce and product development in private corporations which include: TUI Travel PLC, Investec, Zopa and AoL. He is an avid advocate of user centred design and agile ways of working to ensure effective digital services are provided for the end user.


 

Tessa Lewis

Session: Tackling antimicrobial resistance globally and locally

Tessa Lewis
Chair
NICE Management of Common Infections committee

Tessa has been a GP partner, Wales since 1995. As medical advisor, she lead and supported the development of All Wales Medicines Strategy group therapeutic guidance (2005 – 2016), for example, the national antibiotic audit, national prescribing indicators and advice on the role of oral anticoagulants.

She has been involved in various NICE workstreams since 2011 including NICE Antimicrobial Stewardship guideline (Vice chair) and the safe use and management of controlled drugs (NG46 Chair). She is currently a member of NICE Quality Standards and Indicators Advisory Committees and Clinical Guidelines Update Committee (Chair). 

As Chair Wales NICE Liaison Group 2016 -18 she worked with colleagues to support the awareness, discussion and implementation of NICE guidance to people ‘on the front line’.

She also has a particular interest in polypharmacy, multimorbidity and medication review.


 

Richard Vize

Conference chair

Richard Vize
Director
Public Policy Media Ltd

Richard Vize (@RichardVize) has been a commentator on public policy and public services reform for over 25 years. He is a columnist for the Guardian Healthcare Network, contributes to the British Medical Journal and works with a range of organisations across health and local government.

Richard is a former editor of both Health Service Journal and Local Government Chronicle, and was head of communications at regulator Ofsted. He and his teams have won a number of awards.

He is a trustee of the whistleblowing charity Public Concern at Work. Richard’s passions are photography, independent travel and political history.


Susan Hopkins

Session: Tackling antimicrobial resistance globally and locally

Susan Hopkins
Healthcare Epidemiologist Consultant Infectious
Public Health England

Biog to follow


 

Paul Chrisp

Session: Getting the most value out of medicines

Paul Chrisp
Programme Director - Medicines and Technologies Programme
NICE

Paul Chrisp is Programme Director of the Medicines and Technologies Programme at NICE, which supports the appropriate uptake and use of medicines and technologies. The programme also provides resources to demonstrate the impact of new recommendations, and tracks the uptake of guidance.

Paul has been with NICE since March 2009, where he was responsible for setting up the Institute’s accreditation programme, which evaluates the processes used by organisations to develop guidance.


 

Adam Burt

Session: Roadmap for life sciences - interactive session

Adam Burt
Market Access and Public Affairs Director
Novo Nordisk 

Adam Burt is Market Access & Public Affairs Director at Novo Nordisk in the UK. In this role Adam is responsible for ensuring patient access to Novo Nordisk's medicines in the UK, all external communications and partnerships across The Government, and relevant professional and patient organisations including NICE. Adam has been working in the pharmaceutical industry for over 18 years, across different disease areas, large and small pharma companies and in both affiliate and global roles.


 

Dr Bruce Warner

Session: Getting the most value out of medicines

Dr Bruce Warner
Deputy Chief Pharmaceutical Officer
NHS England

Bruce Warner is Deputy Chief Pharmaceutical Officer at NHS England, where he works on the strategic and operational development of medicines and pharmacy policy for NHS England. He has a particular focus on the medicines optimisation and patient safety agendas, and chairs the Medicines Optimisation Intelligence Group that develops the MO dashboard. Bruce’s role also extends to the DH and HEE, and he sits on a number of system wide medicines policy groups.

Prior to this post Bruce worked as Deputy Director of Patient Safety at the NPSA and in NHS England, where he led on the strategy for patient safety improvement and headed up the patient safety advice and guidance function.

Bruce has worked in most sectors of pharmacy including community, hospital, academia and at a PCG/T. He is also a visiting Professor of Pharmacy Practice at the University of Huddersfield.

Twitter: @BruceWarner

LinkedIn: https://www.linkedin.com/in/bruce-warner-2b49b026